Dr. Vicente Riambau y Alonso


· Head of the Service of Angiology and Vascular Surgery at the hospital Clínic de Barcelona.

· Associate professorUniversitat de Barcelona

  • Angiología, cirugía vascular y Endovascular
  • Cirugía Cardiovascular

Select service:


· Bachelor in Medicine and Surgery, Universitat de Barcelona

· PhDUniversitat Autònoma de Barcelona


· More than 30 years of experience

· Pioneer in Spain in the endovascular treatment of aortic aneurysms

· Elected academic of the Royal Academy of Medicine of Catalonia

· Member of the most prestigious scientific societies related to vascular surgery around the world

· He is Visiting ProfessorStanford University (USA), University of Pittsburgh (USA) and University of Belgrade (Serbia)

· He is Expresident of the European Society for Vascular Surgery (ESVS)

· He is president of the American Society of Angiology (Spanish Section)

· He is vicepresident of the ISVS (International Society for Vascular Surgery)

· He is founder and president of the Endovascular Foundation


· Endovascular aortic surgery: Treatment of abdominal and thoracic aortic diseases (aneurysms and dissection) using endoprostheses and catheterization techniques.

· Endovascular and vascular surgery of extremities: open or endovascular surgical techniques for the treatment of limb ischemia and diabetic foot.

· Aortic arch surgery: Conventional and endovascular treatment of blocked extracranial cerebral arteries such as the carotid arteries.

· Treatment of leg varices: prevention and surgical and cosmetic treatment of venous insufficiency and its complications, such as varicose veins and spider veins of the legs. Microphlebectomy, microfoam sclerotherapy.

· Vascular malformations: Combined treatment of tumors, angiomas and various angiodysplasias.


· Endovascular treatment of aortic aneurysms: new prostheses for different pathologies of the aorta, both thoracic and abdominal.

· New materials for the treatment of ischemia: new endovascular elements and pharmacological treatments against chronic ischemia of the lower extremities.

· Gene and cell therapy in vascular pathology: Therapy with biosynthetic growth factors and autologous stem cells for the creation of new blood or lymphatic vessels and / or their repair.

- More than 400 International scientifc papers

- More than 80 book chapters

- More than 500 International talks at international scientific meetings and conferences

- Cumulative impact factor of more than 2.000 points.